MyFinsight
Home
About
Contact
Back
Income Statement
UNITED THERAPEUTICS Corp (UTHR)
source: myfinsight.com
Download
Download image
Product And Service
Other
$5,500K
Adcirca
$6,500K
Nebulized Tyvaso
$154,400K
Orenitram
$123,900K
Remodulin
$134,700K
Tyvaso DPI
$315,200K
Unituxin
$58,400K
Interest income
$51,300K
(11.04%↑ Y/Y)
Total revenues
$798,600K
(11.71%↑ Y/Y)
Total other income,
net
$43,900K
(24.01%↑ Y/Y)
Operating income
$364,500K
(13.94%↑ Y/Y)
Interest expense
$7,300K
(-37.07%↓ Y/Y)
Other (expense)
income, net
-$100K
(-112.50%↓ Y/Y)
Total operating
expenses
$434,100K
(9.90%↑ Y/Y)
Income before income
taxes
$408,400K
(14.95%↑ Y/Y)
Cost of sales
$87,600K
(12.60%↑ Y/Y)
Research and development
$134,000K
(-4.01%↓ Y/Y)
Selling, general, and
administrative
$212,500K
(19.65%↑ Y/Y)
Net income
$309,500K
(11.29%↑ Y/Y)
Income tax expense
$98,900K
(28.11%↑ Y/Y)
Back